Physician profile
Parth Sheth
NPI 1184114837
$670.05
in general payments reported to CMS, 2019-2025
9 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $19.18 · 2022: $162 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.74 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $241.42 | 2021-2025 | Ultomiris |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2022 | |
| Amgen INC. | $122.06 | 2019 | |
| Ucb, INC. | $53.54 | 2025 | Rystiggo, Zilbrysq |
| Biogen, INC. | $43.69 | 2025 | Leqembi, Vumerity, Tysabri |
| Neurelis, INC. | $26.45 | 2025 | Valtoco |
| Lundbeck LLC | $23.00 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $17.71 | 2025 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $17.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.